Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu Huang

Showing results (1171-1180 of 1,485) with videos related to

Pageof 149
Sort By:
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Research in Developmental Disabilities|May 2, 2017
The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in TaiwanWu-Chien Chien, Chi-Hsiang Chung, Fu-Huang Lin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisBenjamin F Combes, Alicia Rosenau, Sheng-Fu Huang, et al.
Medicine|February 13, 2016
Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal CarcinomaShy-Chyi Chin, Chien-Yu Lin, Bing-Shen Huang, et al.
Plos One|March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patientsChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2006
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinomaTzu-Chen Yen, Chien-Yu Lin, Hung-Ming Wang, et al.
Journal of Hepatology|June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirinChung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Plos One|September 23, 2016
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-AnalysisChin Lin, Hsiang-Cheng Chen, Wen-Hui Fang, et al.
International Journal of Pharmaceutics|October 8, 2021
An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseasesHelen Haixia Wu, Kerry-Leigh Ralph, Eliud Sepuldeva, et al.
Oral Oncology|June 1, 2017
Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single centerLi-Rong Wu, Ya-Tian Liu, Ning Jiang, et al.
Pageof 149

Showing results (1171-1180 of 1,485) with videos related to

Sort By:
Pageof 149
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Research in Developmental Disabilities|May 2, 2017
The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in TaiwanWu-Chien Chien, Chi-Hsiang Chung, Fu-Huang Lin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisBenjamin F Combes, Alicia Rosenau, Sheng-Fu Huang, et al.
Medicine|February 13, 2016
Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal CarcinomaShy-Chyi Chin, Chien-Yu Lin, Bing-Shen Huang, et al.
Plos One|March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patientsChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2006
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinomaTzu-Chen Yen, Chien-Yu Lin, Hung-Ming Wang, et al.
Journal of Hepatology|June 28, 2011
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirinChung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, et al.
Plos One|September 23, 2016
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-AnalysisChin Lin, Hsiang-Cheng Chen, Wen-Hui Fang, et al.
International Journal of Pharmaceutics|October 8, 2021
An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseasesHelen Haixia Wu, Kerry-Leigh Ralph, Eliud Sepuldeva, et al.
Oral Oncology|June 1, 2017
Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single centerLi-Rong Wu, Ya-Tian Liu, Ning Jiang, et al.
Pageof 149